Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology

Clinical Trials: Von Willebrand Disease


A listing of clinical trials currently looking for volunteers to enroll in Von Willebrand Disease studies. Click on the closest city to find more detailed information on a research study in your area.

Illinois

Peoria : University of Illinois College of Medicine at Peoria

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Indiana

Indianapolis : Indiana Hemophilia and Thrombosis Center

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

New Jersey

Newark : Newark Beth Israel Medical Center

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

New York

Rochester : The Mary M Gooley Hemophilia Center and Rochester General Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

North Carolina

Chapel Hill : University of North Carolina at Chapel Hill

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Chapel Hill : Rho, Inc.

The Von Willebrand Disease (VWD) International Prophylaxis Study

Oklahoma

Oklahoma City : Oklahoma Center for Bleeding and Clotting Disorders

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients

Pennsylvania

Philadelphia : Pennsylvania Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pittsburgh : Hemophilia Center of Western Pennsylvania

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Wisconsin

Milwaukee : Blood Center of Wisconsin

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Milwaukee : BloodCenter of Wisconsin

The Von Willebrand Disease (VWD) International Prophylaxis Study

Australia

Adelaide : Royal Adelaide Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Perth : Royal Perth Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Austria

Vienna : Medical University Vienna

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Belgium

Bruxelles : Cliniques Universitaires Saint-Luc

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Leuven : UZ Leuven

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Bulgaria

Sofia : Specialized Haematological Hospital "Joan Pavel"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Varna : Multiprofile Hospital for Active Treatment "Sveta Marina"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Canada

Montreal : Maisonneuve-Rosemont Hospital

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

Germany

Berlin : Vivantes Klinikum im Friedrichshain

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Duisburg : Gerinnungszentrum Rhein-Ruhr

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Mainz : Universitätsmedizin der Johannes Gutenberg Universität Mainz

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

India

Pune : Jehangir Clinical Development Centre Pvt. Ltd.

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pune : Sahyadri Speciality Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Vellore : Christian Medical College

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Italy

Florence : Azienda Ospedaliera Universitaria Careggi

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Milano : Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Roma : Università degli Studi di Roma "La Sapienza"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Vicenza : Ospedale San Bortolo

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Japan

Tokyo : Tokyo Medical University Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Netherlands

Rotterdam : Erasmus MC

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Poland

Warsaw : Institute of Haematology and Transfusion Medicine

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Sweden

Gothenburg : Sahlgrenska Universitetssjukhuset

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Malmö : Skåne University Hospital

The Von Willebrand Disease (VWD) International Prophylaxis Study

Malmoe : Skåne University Hospital (SUS)

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

United Kingdom

London : Royal Free Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

London : Hammersmith Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

London : The Royal London Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)